On November 14, 2025, at 15:00, at the COA Jianjia exhibition booth, our two core products—Arthrobot and YOZX —proudly unveiled the "10000+" milestone banner. This marked the first time a domestic orthopedic robot company utilized a "Multi-Robot Coordination" approach to showcase its achievement as a verifiable technical demonstration. In just four years, working with over a thousand hospitals and covering Hip, Knee, Unicompartmental Knee, Spine, and Trauma, Jianjia Medical has fully exemplified the "China Speed" in orthopedic innovation.
At the ceremony, we were honored by the presence of key opinion leaders from the orthopedic field, including Professor Wang Kunzheng (President of the Chinese Orthopaedic Association, The Second Affiliated Hospital of Xi'an Jiaotong University) and Professor Ma Xinlong (President-elect of the Chinese Orthopaedic Association, Tianjin Hospital). They joined the representatives on site to share in this momentous industry occasion.
Q1: What is the surgical accuracy of Jianjia’s robots?
Jianjia surgical robots are equipped with two precision technologies—Haptic Virtual Boundary and Real-time High-speed Parallel Rendering—ensuring safety and delivering clinical results with sub-millimeter surgical accuracy.
Q2: How convenient are Jianjia’s robots to operate?
The operational convenience of Jianjia surgical robots is supported by 10,000 clinical cases: Once surgeons navigate the learning curve, robot-assisted procedures do not add to the overall surgery time. In fact, our precise intelligent assistance and user-friendly design enable more efficient surgical execution, providing a solution that is both safe and highly efficient for the clinic.
Q3: What is the scope of indications covered by Jianjia’s robots?
The indications for Jianjia’s two orthopedic surgical robots are extensive:
Arthrobot: Hip, Knee, Unicompartmental Knee
YOZX: Spine, Trauma, Hip, Knee
Q4: What are the surgical outcomes of Jianjia’s robots?
Analysis of the 10,000 cases shows that patients who undergo robot-assisted surgery benefit from a shortened Average Length of Stay (ALOS) and a reduction in the comprehensive cost per case.
Jianjia has established the Jianjia Orthopedic Surgical Robot Asia-Pacific Clinical Training Center at the National Orthopedic Medical Center (Shanghai Sixth People's Hospital). Moving forward, Jianjia will work closely with more top medical centers and partners to co-develop a "Robotic Surgery Quality Control Database."
During this COA, Jianjia also jointly launched the Surgical Robot Remote Teaching System with the First Affiliated Hospital of Sun Yat-sen University. Utilizing 5G+AI technology, this system will leverage the hospital’s academic and clinical strengths to elevate the skills of orthopedic surgeons nationwide, setting a gold standard for building a high-quality collaborative teaching network.
We are proud that in July 2025, the orthopedic team at the First Affiliated Hospital of Jinan University used the Arthrobot to live-stream several complex robot-assisted joint replacement surgeries to peers globally, which drew nearly 100,000 online viewers.
Starting in 2026, Jianjia is set to train and certify at least 200 surgeons per year in "Standardized Robotic Surgery," targeting coverage in 80% of Chinese provinces and cities.
We announce:
We will launch the "Second 10,000 Milestone" plan in 2026, with the vision of covering 80% of the nation's provinces and cities. We are committed to closing the "last mile" gap for robot-assisted orthopedic surgery, ensuring that precision is not a luxury, but becomes an affordable standard.
